La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction

Identifieur interne : 003991 ( Main/Exploration ); précédent : 003990; suivant : 003992

Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction

Auteurs : Claus Rinne [Canada] ; Arjun D. Sharma [Canada] ; George J. Klein [Canada] ; Raymond Yee [Canada] ; Tibor Szabo [Canada]

Source :

RBID : ISTEX:C812E7C76F5037CD010C958CA6A8C2E38AAA4DBB

Abstract

Adenosine triphosphate (ATP) has potent negative dromotropic effects on the atrioventricular (AV) node, but variable effects on accessory pathway conduction have been described. The effects of an intravenous bolus injection of 8 mg ATP on accessory pathway and AV nodal conduction were determined during electrophysiologic testing with controlled atrial and ventricular rates. AV conduction was monitored during atrial or ventricular pacing at a constant cycle length, 30 msec longer than the cycle length at which block occurred. During atrial pacing antegrade block after administration of ATP occurred in 1 of 30 (3.2%) patients with accessory pathway conduction and 12 of 13 (92%) patients with AV nodal conduction (p < 0.001). During ventricular pacing only 5 of 26 (16%) patients had accessory pathways blocked, whereas 25 of 35 (71%) patients with AV nodal conduction had block (p < 0.001). Thus, failure of ATP to produce ventriculoatrial block identified the presence of an accessory pathway with a sensitivity of 84%, specificity of 71%, and predictive value of 72%. There was no correlation between accessory pathway properties and the effects of ATP. The effects of ATP on the AV node were concordant with the effects of a combination of verapamil and propranolol in 21 to 23 patients, suggesting that this dose ATP is an equipotent AV nodal blocker with a short duration of action. Thus, although the effects of ATP on accessory pathways and the AV node differ, block in ventriculoatrial conduction after administration of ATP cannot be used as the sole criterion to distinguish the mechanism of conduction.

Url:
DOI: 10.1016/0002-8703(88)90074-9


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction</title>
<author>
<name sortKey="Rinne, Claus" sort="Rinne, Claus" uniqKey="Rinne C" first="Claus" last="Rinne">Claus Rinne</name>
</author>
<author>
<name sortKey="Sharma, Arjun D" sort="Sharma, Arjun D" uniqKey="Sharma A" first="Arjun D" last="Sharma">Arjun D. Sharma</name>
</author>
<author>
<name sortKey="Klein, George J" sort="Klein, George J" uniqKey="Klein G" first="George J" last="Klein">George J. Klein</name>
</author>
<author>
<name sortKey="Yee, Raymond" sort="Yee, Raymond" uniqKey="Yee R" first="Raymond" last="Yee">Raymond Yee</name>
</author>
<author>
<name sortKey="Szabo, Tibor" sort="Szabo, Tibor" uniqKey="Szabo T" first="Tibor" last="Szabo">Tibor Szabo</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C812E7C76F5037CD010C958CA6A8C2E38AAA4DBB</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1016/0002-8703(88)90074-9</idno>
<idno type="url">https://api-v5.istex.fr/document/C812E7C76F5037CD010C958CA6A8C2E38AAA4DBB/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001735</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001735</idno>
<idno type="wicri:Area/Istex/Curation">001735</idno>
<idno type="wicri:Area/Istex/Checkpoint">001549</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001549</idno>
<idno type="wicri:doubleKey">0002-8703:1998:Rinne C:comparative:effects:of</idno>
<idno type="wicri:Area/Main/Merge">004006</idno>
<idno type="wicri:Area/Main/Curation">003991</idno>
<idno type="wicri:Area/Main/Exploration">003991</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction</title>
<author>
<name sortKey="Rinne, Claus" sort="Rinne, Claus" uniqKey="Rinne C" first="Claus" last="Rinne">Claus Rinne</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University Hospital, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sharma, Arjun D" sort="Sharma, Arjun D" uniqKey="Sharma A" first="Arjun D" last="Sharma">Arjun D. Sharma</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University Hospital, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Klein, George J" sort="Klein, George J" uniqKey="Klein G" first="George J" last="Klein">George J. Klein</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University Hospital, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yee, Raymond" sort="Yee, Raymond" uniqKey="Yee R" first="Raymond" last="Yee">Raymond Yee</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University Hospital, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Szabo, Tibor" sort="Szabo, Tibor" uniqKey="Szabo T" first="Tibor" last="Szabo">Tibor Szabo</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University Hospital, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">American Heart Journal</title>
<title level="j" type="abbrev">YMHJ</title>
<idno type="ISSN">0002-8703</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1998">1998</date>
<biblScope unit="volume">115</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="1042">1042</biblScope>
<biblScope unit="page" to="1047">1047</biblScope>
</imprint>
<idno type="ISSN">0002-8703</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0002-8703</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Adenosine triphosphate (ATP) has potent negative dromotropic effects on the atrioventricular (AV) node, but variable effects on accessory pathway conduction have been described. The effects of an intravenous bolus injection of 8 mg ATP on accessory pathway and AV nodal conduction were determined during electrophysiologic testing with controlled atrial and ventricular rates. AV conduction was monitored during atrial or ventricular pacing at a constant cycle length, 30 msec longer than the cycle length at which block occurred. During atrial pacing antegrade block after administration of ATP occurred in 1 of 30 (3.2%) patients with accessory pathway conduction and 12 of 13 (92%) patients with AV nodal conduction (p < 0.001). During ventricular pacing only 5 of 26 (16%) patients had accessory pathways blocked, whereas 25 of 35 (71%) patients with AV nodal conduction had block (p < 0.001). Thus, failure of ATP to produce ventriculoatrial block identified the presence of an accessory pathway with a sensitivity of 84%, specificity of 71%, and predictive value of 72%. There was no correlation between accessory pathway properties and the effects of ATP. The effects of ATP on the AV node were concordant with the effects of a combination of verapamil and propranolol in 21 to 23 patients, suggesting that this dose ATP is an equipotent AV nodal blocker with a short duration of action. Thus, although the effects of ATP on accessory pathways and the AV node differ, block in ventriculoatrial conduction after administration of ATP cannot be used as the sole criterion to distinguish the mechanism of conduction.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Rinne, Claus" sort="Rinne, Claus" uniqKey="Rinne C" first="Claus" last="Rinne">Claus Rinne</name>
</noRegion>
<name sortKey="Klein, George J" sort="Klein, George J" uniqKey="Klein G" first="George J" last="Klein">George J. Klein</name>
<name sortKey="Sharma, Arjun D" sort="Sharma, Arjun D" uniqKey="Sharma A" first="Arjun D" last="Sharma">Arjun D. Sharma</name>
<name sortKey="Szabo, Tibor" sort="Szabo, Tibor" uniqKey="Szabo T" first="Tibor" last="Szabo">Tibor Szabo</name>
<name sortKey="Yee, Raymond" sort="Yee, Raymond" uniqKey="Yee R" first="Raymond" last="Yee">Raymond Yee</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003991 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003991 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C812E7C76F5037CD010C958CA6A8C2E38AAA4DBB
   |texte=   Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022